Contract development and manufacturing organization SpectronRx has appointed Peter Webner as its new chief operating officer (COO).
Webner brings more than three decades of nuclear medicine and radiopharmaceutical industry experience to his new position. He has previously served as general manager of breast oncology ultrasound and global executive medical imaging advisor at GE Healthcare. He was instrumental in GE's acquisition of Zionexa and acted as its chief executive officer. He is a licensed nuclear medicine technologist and has held leadership positions at Zevacor Molecular, Zevacor Pharma, Eastern Isotopes, IBA Molecular, Positron, and Mt. Sinai Medical Center in New York, SpectronRx said.